Kahn Clare bought STOK
April 3, 2026 · Form 4 insider transaction
Kahn Clare bought 30,782 shares of Stoke Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,782
Price
$0.00
Total value
N/A
InsiderKahn Clare
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateApril 3, 2026
Filing dateApril 7, 2026
Shares owned after30,782
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option award shall vest as to 1/12 of the total award quarterly on the first calendar day of each July, October, January, and April, with the first tranche vesting on July 1, 2026, subject to the reporting person's continued service to the Issuer through each vesting date.